Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Use of CFTR modulators in patients having undergone liver transplantation

Use of CFTR modulators in patients having undergone liver transplantation

Resource Type

CF Research News

Authors

Diana Coman, Catherine Vincent, Genevieve Huard, Denis Marleau, Annick Lavoie, Julian Hercun

References

J Cyst Fibros. 2023 Nov 23:S1569-1993(23)01675-2. doi: 10.1016/j.jcf.2023.11.004.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Keywords

CFTR modulators [3]
Cystic fibrosis liver disease [4]
Elexacaftor/tezacaftor/ivacaftor [5]
Liver transplant [6]

Date

Thursday, November 23, 2023

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [7]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/use-cftr-modulators-patients-having-undergone-liver

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-23-00377R1_FINAL_Coman_210124.pdf [2] https://pubmed.ncbi.nlm.nih.gov/38000917/ [3] https://www.ecfs.eu/research-article-keywords/cftr-modulators [4] https://www.ecfs.eu/research-article-keywords/cystic-fibrosis-liver-disease [5] https://www.ecfs.eu/research-article-keywords/elexacaftortezacaftorivacaftor [6] https://www.ecfs.eu/research-article-keywords/liver-transplant [7] https://www.ecfs.eu/resource-guideline-type/other-guidelines